AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Sergiglid M 80 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sergio Remedies Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Sergiglid M 80 Tablet SR

Diabetol Duo 80mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo 80mg Extended-Release should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your glycemic response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting sugar source to counter hypoglycemia and maintain regular mealtimes. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a potential consequence for some users. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before initiating this medication. Regular blood glucose monitoring is necessary, alongside periodic blood tests to assess blood cell counts and liver function.

Uses of Sergiglid M 80 Tablet SR

Adult-onset diabetes

Major Benefits of Sergiglid M 80 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sergiglid M 80 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. Administer this medication with food.

Common Side effects of Sergiglid M 80 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Sergiglid M 80 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sergiglid M 80 Tablet SR. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with a meal.

How Sergiglid M 80 Tablet SR works:

Sergiglid M 80 extended-release tablets contain a dual anti-diabetic formulation comprising gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Sergiglid M 80 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sergiglid M 80 Tablet SR is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sergiglid M 80mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sergiglid M 80 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is essential. Sergiglid M 80 Tablet SR is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Sergiglid M 80 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, it's unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Sergiglid M 80 Tablet SR :

Should you forget a dose of Sergiglid M 80 Tablet SR, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sergiglid M 80 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sergiglid M 80 Tablet SR

Sergiglid M 80 Tablet SR combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Sergiglid M 80 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Sergiglid M 80 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Sergiglid M 80 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid. Also known as MALA (Metformin-associated lactic acidosis), this rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sergiglid M 80 Tablet SR and seek immediate medical attention.
Prolonged use of Sergiglid M 80 Tablet SR can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually.
Sergiglid M 80 Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol with Sergiglid M 80 Tablet SR is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Sergiglid M 80 Tablet SR combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 DM.
Sergiglid M 80 Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Sergiglid M 80 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Sergiglid M 80 Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is less likely in patients without kidney disease, who are not elderly, and who do not consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sergiglid M 80 Tablet SR and seek immediate medical attention.
Prolonged Sergiglid M 80 Tablet SR use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (including tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sergiglid M 80 Tablet SR is contraindicated in patients with allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Sergiglid M 80 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and increase the risk of lactic acidosis.
Sergiglid M 80 Tablet SR
118
MRP 144
18% off